1 entry found
1
Journal article icon

Journal article

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)

  • Pouleur, A-C, Anker, S, Brito, D, et al.
  • 2018-06-22
FILTER RESULTS

TO TOP